![Seth V. Hetherington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seth V. Hetherington
Directeur/Bestuurslid bij Apie Therapeutics, Inc.
Profiel
Seth V.
Hetherington is currently a Director at Apie Therapeutics, Inc. He previously held positions as Chief Medical Officer & VP-Clinical Development at Inhibitex LLC, SVP-Clinical & Regulatory Affairs at Neusentis, Inc., Chief Medical Officer at Genocea Biosciences, Inc., and Senior VP-Clinical & Regulatory Affairs at Icagen, Inc. He also worked as Head-Clinical Program at GlaxoSmithKline, Inc. and Glaxo Wellcome, Inc. Additionally, he worked as a Principal at The University of North Carolina at Asheville.
Hetherington received his undergraduate degree from Yale University and his doctorate from The University of North Carolina at Asheville.
Actieve functies van Seth V. Hetherington
Bedrijven | Functie | Begin |
---|---|---|
Apie Therapeutics, Inc.
![]() Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Seth V. Hetherington
Bedrijven | Functie | Einde |
---|---|---|
GENOCEA BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 30-01-2018 |
Neusentis, Inc.
![]() Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2010 |
Icagen, Inc.
![]() Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2010 |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Hoofd Techniek/Wetenschap/O&O | 01-06-2006 |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01-06-2002 |
Opleiding van Seth V. Hetherington
Yale University | Undergraduate Degree |
The University of North Carolina at Asheville | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENOCEA BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Neusentis, Inc.
![]() Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Health Technology |
Icagen, Inc.
![]() Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | Health Technology |
Apie Therapeutics, Inc.
![]() Apie Therapeutics, Inc. Medical/Nursing ServicesHealth Services Apie Therapeutics, Inc. provides healthcare services. The private company is based in Durham, NC. The company was founded by Esther M. Alegria. Ashwin Datt has been the CEO of the company since 2023. | Health Services |